Results 101 to 110 of about 23,422 (206)

RETRACTED: lncRNA MALAT1 Accelerates Wound Healing of Diabetic Mice Transfused with Modified Autologous Blood via the HIF-1α Signaling Pathway [PDF]

, 2019
Xiaoqian Liu, Li‐Shuang Duan, Yongquan Chen, Xiaoju Jin, Na‐Na Zhu, Xun Zhou, Han‐Wei Wei, Lei Yin, Jian‐Rong Guo   +8 more
openalex   +1 more source

MeMAGEN: A Phase IIa/IIb open‐label trial of memantine testing safety and tolerability in sickle cell patients

HemaSphere, Volume 10, Issue 1, January 2026.
ABSTRACT Administration of memantine, an antagonist of the N‐methyl‐ d‐aspartate receptor, prevents Ca2+ overload and dehydration of red blood cells (RBCs) in patients with sickle cell disease (SCD). The objectives of the 1‐year dose‐escalation Phase IIa/IIb Memantine trial (MeMAGEN – NCT 03247218) with 17 SCD patients who were under stable ...
Ariel Koren, Carina Levin, Leonid Livshits, Fabio Valeri, Sari Peretz, Sivan Raz, Anna Yu Bogdanova, Max Gassmann   +7 more
wiley   +1 more source

THE PORTION OF AUTOLOGOUS BLOOD IN ORTHOPEDIC DEPARTMENT OF GENERAL HOSPITAL NOVA GORICA IN FIVE YEARS PERIOD (1996–2000)

Zdravniški Vestnik, 2002
Background. The presentation of autologous blood donation with analysis of used blood and the percentage of autologous blood on Orthopedic Department in the years 1996–2000.Methods.
Janka Černe-Zavadlav, Željko Mihelič, Albin Plahuta   +2 more
doaj  

Clinical efficacy of a novel autologous blood recovery device during ECMO weaning

Zhongguo shuxue zazhi
[Objective] To evaluate the clinical efficacy of a novel autologous blood recovery device during the weaning process from extracorporeal membrane oxygenation (ECMO).
LU Yufeng, ZHANG Chuanfa, FAN Dongmei, HU Shuo, WEN Xianming, LIU Ziyou   +5 more
doaj   +1 more source

Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High‐Dose Cytarabine‐Based Chemotherapy as Second‐Line Treatments for Relapsed or Refractory Diffuse Large B‐Cell Lymphoma

Hematological Oncology, Volume 44, Issue 1, January 2026.
ABSTRACT The optimal second‐line chemotherapy regimen for relapsed or refractory diffuse large B‐cell lymphoma (R/R DLBCL) remains uncertain. We retrospectively compared efficacy and safety between gemcitabine, carboplatin, dexamethasone, and rituximab (GCD‐R) and cyclophosphamide, high‐dose cytarabine, dexamethasone, etoposide, and rituximab (CHASER ...
Yoshikazu Ikoma, Nobuhiko Nakamura, Junichi Kitagawa, Naoki Hayase, Eri Takada, Takuro Matsumoto, Yuhei Shibata, Hiroshi Nakamura, Kei Fujita, Shin Lee, Tetsuji Morishita, Nobuhiro Kanemura, Senji Kasahara, Hideko Goto, Kenji Fukuno, Takeshi Hara, Michio Sawada, Hisashi Tsurumi, Masahito Shimizu   +18 more
wiley   +1 more source

Effects of Pre-Donated Autologous Blood Transfusion on Peri-Operative Hemoglobin Concentration and Mid-Term Health Outcomes in Primary Total Knee Arthroplasty. [PDF]

J Clin Med, 2022
Tomura J, Morikawa D, Nozawa M, Ishijima M, Kim SG.   +4 more
europepmc   +1 more source

Feasibility and effectiveness of the novel HemoClear microfiltration cell‐salvage system in cesarean sections in South Africa

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 396-405, January 2026.
Abstract Objective To test the feasibility and effectiveness of implementing the HemoClear microfiltration cell‐salvage system for cesarean sections in South Africa. Methods We conducted a prospective experimental single‐arm feasibility study collecting and processing blood from 20 adult women undergoing cesarean section in Pelonomi Tertiary Hospital ...
Nndwammbi C. Ramatsea, Marnus Booyens, Joseph B. Sempa, Angélique B. van 't Wout, Edwin Turton, Arno P. Nierich   +5 more
wiley   +1 more source

Autologous Blood Transfusion in Surgical Outreach Camp

, 2015
Apurb Sharma, Balkrishna Bhattarai
openalex   +2 more sources

Melanoma: Pathogenesis and Targeted Therapy

MedComm, Volume 7, Issue 1, January 2026.
The treatment landscape for advanced melanoma has evolved significantly. BRAF–MEK inhibitor combinations are standard for BRAF‐mutant melanoma, whereas targeting NRAS mutations is more challenging, with MEK inhibitors like tunlametinib emerging as an option.
Yang Fu, Jie Liu, Zeming Mo, Bin Wang, Yaotiao Deng, Yu Jiang   +5 more
wiley   +1 more source

Molecular Mechanism Exploration of Autologous Blood Transfusion with RBC Surface Membrane Protein pMHC/aCD28 Combined with CD8+T Cells to Promote the Proliferation of CD8+T Cells to Inhibit the Malignant Transformation of Liver Cancer. [PDF]

J Oncol, 2022
Tao H, Liu T, Yao N, Wang J, Xu J, Zhou X, Chen X, Guo J.   +7 more
europepmc   +1 more source